These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10901752)

  • 1. The prospects for antisense therapy.
    Gewirtz AM
    Hosp Pract (1995); 1999 Sep; 34(10):97-107; quiz 141. PubMed ID: 10901752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems.
    Clark RE
    Leukemia; 2000 Mar; 14(3):347-55. PubMed ID: 10720125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for chronic myelogenous leukemia.
    Verfaillie CM; McIvor RS; Zhao RC
    Mol Med Today; 1999 Aug; 5(8):359-66. PubMed ID: 10431169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of CRISPR/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapy.
    Liu Y; Zhao G; Xu CF; Luo YL; Lu ZD; Wang J
    Biomater Sci; 2018 May; 6(6):1592-1603. PubMed ID: 29725684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenesis imperfecta. Rehabilitation and prospects for gene therapy.
    Marini JC; Gerber NL
    JAMA; 1997 Mar; 277(9):746-50. PubMed ID: 9042848
    [No Abstract]   [Full Text] [Related]  

  • 6. Antisense oncogene and tumor suppressor gene therapy of cancer.
    Zhang WW
    J Mol Med (Berl); 1996 Apr; 74(4):191-204. PubMed ID: 8740650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is antisense gene therapy a step in the right direction in the control of hypertension?
    Raizada MK; Katovich MJ; Wang H; Berecek KH; Gelband CH
    Am J Physiol; 1999 Aug; 277(2):H423-32. PubMed ID: 10444465
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy for gastric cancer: problems and prospects.
    Steele RJ; Lane DP
    Surg Oncol; 2000 Jul; 9(1):13-6. PubMed ID: 11525301
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular targeting therapy for chronic myelogenous leukemia].
    Ono R
    Nihon Naika Gakkai Zasshi; 2003 May; 92(5):884-9. PubMed ID: 12808916
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins.
    Morgan RA; Walker R
    Hum Gene Ther; 1996 Jun; 7(10):1281-306. PubMed ID: 8793552
    [No Abstract]   [Full Text] [Related]  

  • 11. BCR-ABL: an anti-apoptosis gene in chronic myelogenous leukemia.
    Cotter TG
    Leuk Lymphoma; 1995 Jul; 18(3-4):231-6. PubMed ID: 8535187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense inhibition of P210 bcr-abl in chronic myeloid leukemia.
    Vaerman JL; Lewalle P; Martiat P
    Stem Cells; 1993 Oct; 11 Suppl 3():89-95. PubMed ID: 8298481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonuclease H-mediated antisense effects in intact human leukaemia cells.
    Tidd DM
    Biochem Soc Trans; 1996 Aug; 24(3):619-23. PubMed ID: 8878815
    [No Abstract]   [Full Text] [Related]  

  • 14. Morpholino Oligo Antisense efficiently suppresses BCR/ABL and cell proliferation in CML: specific inhibition of BCR-ABL gene expression by Morpholino Oligo Antisense in BCR-ABL(+) cells.
    Haririan M; Kaviani S; Soleimani M; Ghaemi SR; Delalat B; Atashi A
    Hematology; 2012 Jan; 17(1):28-34. PubMed ID: 22549445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of oncogene expression by antisense nucleic acids.
    Hélène C
    Eur J Cancer; 1994; 30A(11):1721-6. PubMed ID: 7833151
    [No Abstract]   [Full Text] [Related]  

  • 16. [Target therapy for CML--applying maxizyme].
    Tani K
    Nihon Rinsho; 2001 Dec; 59(12):2439-44. PubMed ID: 11766353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense gene therapy trials underway in patients with CML.
    Oncology (Williston Park); 1996 Sep; 10(9):1411. PubMed ID: 8882929
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent progress in diagnosis of and therapy for patients with leukemia].
    Ueda T
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):574-9. PubMed ID: 15052823
    [No Abstract]   [Full Text] [Related]  

  • 19. Sense, antisense, nonsense: where's the right way?
    Bricca G
    J Mol Med (Berl); 1995 Aug; 73(8):417-9. PubMed ID: 8528744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.